Arteris, Inc. (NASDAQ:AIP – Get Free Report) CFO Nicholas Hawkins sold 4,472 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $15.45, for a total transaction of $69,092.40. Following the completion of the transaction, the chief financial officer directly owned 87,959 shares of the company’s stock, valued at approximately $1,358,966.55. This represents a 4.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Arteris Stock Performance
Shares of NASDAQ AIP opened at $17.42 on Thursday. The firm has a market cap of $760.91 million, a P/E ratio of -20.99 and a beta of 1.48. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85. The firm’s 50 day moving average price is $15.27 and its 200 day moving average price is $12.05.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The business had revenue of $17.41 million for the quarter, compared to analysts’ expectations of $17.00 million. As a group, equities analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.
Arteris News Roundup
- Positive Sentiment: Several institutional investors increased or initiated positions (AQR, Acadian, Jacobs Levy, IEQ), signaling continued institutional interest that can support the stock. MarketBeat: Arteris overview
- Neutral Sentiment: Recent quarterly results: Arteris reported EPS of ($0.09) vs. consensus ($0.11) and revenue $17.41M vs. $17.00M — a small beat that supports fundamentals but the company remains unprofitable on a GAAP basis. Analysts have a consensus target ~ $17.50 (Moderate Buy). MarketBeat: Earnings & analyst notes
- Neutral Sentiment: Technical/context: AIP is trading above its 50-day ($15.20) and 200-day ($12.01) moving averages, which can limit downside for some technical traders. MarketBeat: Price data
- Negative Sentiment: Heavy insider selling this week: CEO K. Charles Janac, COO Laurent Moll, CFO Nicholas Hawkins and VP Paul Alpern sold multiple blocks (several thousand shares each) at prices roughly $15.45–$16.89 across Jan. 2–6. Collective insider sales reduce insider ownership and can be interpreted negatively by the market even though insiders still hold sizable stakes. InsiderTrades: Jan 7 summary
Hedge Funds Weigh In On Arteris
A number of hedge funds have recently made changes to their positions in the business. Penn Capital Management Company LLC purchased a new stake in Arteris during the 3rd quarter worth $109,000. Worth Venture Partners LLC raised its position in Arteris by 24.2% in the third quarter. Worth Venture Partners LLC now owns 58,731 shares of the company’s stock valued at $593,000 after purchasing an additional 11,446 shares during the period. Westerly Capital Management LLC lifted its stake in shares of Arteris by 109.6% during the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after purchasing an additional 745,000 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Arteris in the third quarter worth about $113,000. Finally, Public Employees Retirement System of Ohio boosted its position in shares of Arteris by 12.3% in the third quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company’s stock worth $242,000 after buying an additional 2,613 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Rosenblatt Securities reaffirmed a “buy” rating and set a $20.00 price objective on shares of Arteris in a research note on Monday, December 15th. Cowen reissued a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, October 8th. TD Cowen increased their price target on shares of Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a report on Tuesday, October 28th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $17.50.
View Our Latest Analysis on AIP
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
- Five stocks we like better than Arteris
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
